{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T08:11:46Z","timestamp":1788509506663,"version":"build-2803163510"},"posted":{"date-parts":[[2025,7,14]]},"group-title":"In Review","reference-count":0,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T00:00:00Z","timestamp":1752451200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2025,7,6]]},"abstract":"<title>Abstract<\/title>\n                <p>The anti-apoptotic molecule BCL-2 favors the maintenance of the CD4+ T-cell reservoir during Human Immunodeficiency Virus (HIV) infection. We investigated directly in-vivo whether BCL-2 inhibition using venetoclax at the initiation of antiretroviral therapy (ART) would reduce the size of the viral reservoir. Twenty-four SIVmac239-infected rhesus macaques (RMs) initiated ART at day 14 post-infection (p.i.), alone or with a 10-day treatment with venetoclax or venetoclax plus CD8\u03b1 depletion, and followed up to day 294 p.i. A rapid, statistically significant, and sustained reduction in the intact SIV reservoir was observed in venetoclax-treated RMs in blood and lymph nodes (LNs). This reduction was driven by reduced survival and depletion of CD4+ T-cell subsets that critically contribute to the reservoir. CD4+ T-cells that persisted after venetoclax treatment exhibited elevated per-cell levels of BCL-2, reduced expression of pro-apoptotic molecules such as PUMA, increased expression of additional anti-apoptotic molecules, including BCL-xL, and a partial reduction in apoptotic sensitivity in ex vivo assays. These findings provide mechanistic insights for the venetoclax-induced pro-cell death changes in CD4+ T-cells, support the rationale for extended venetoclax dosing, and suggest that combining BCL-2 inhibition with agents targeting additional anti-apoptotic molecules can enhance clearance of the viral reservoir in HIV cure strategies.<\/p>","DOI":"10.21203\/rs.3.rs-7060088\/v1","type":"posted-content","created":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T03:43:27Z","timestamp":1752464607000},"source":"Crossref","is-referenced-by-count":1,"title":["BCL-2 Inhibition via Venetoclax at ART Initiation Induces Long-Term Reduction of the Intact SIV Reservoir"],"prefix":"10.21203","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7276-3600","authenticated-orcid":false,"given":"Mirko","family":"Paiardini","sequence":"first","affiliation":[{"name":"Emory University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8806-4700","authenticated-orcid":false,"given":"Tomas Raul Wiche","family":"Salinas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6948-3501","authenticated-orcid":false,"given":"Justin","family":"Harper","sequence":"additional","affiliation":[{"name":"Emory University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3507-0055","authenticated-orcid":false,"given":"Claire","family":"Deleage","sequence":"additional","affiliation":[{"name":"Frederick National Laboratory for Cancer Research"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Emory University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Auger","sequence":"additional","affiliation":[{"name":"Emory University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Flores","sequence":"additional","affiliation":[{"name":"Emory University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia","family":"Wilkes","sequence":"additional","affiliation":[{"name":"Emory University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachelle","family":"Stammen","sequence":"additional","affiliation":[{"name":"Emory University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Wood","sequence":"additional","affiliation":[{"name":"Emory University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3075-755X","authenticated-orcid":false,"given":"Gregory","family":"Tharp","sequence":"additional","affiliation":[{"name":"Yerkes National Primate Research Center, Emory University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2116-5061","authenticated-orcid":false,"given":"Steven","family":"Bosinger","sequence":"additional","affiliation":[{"name":"Emory University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mackenzie","family":"Cottrell","sequence":"additional","affiliation":[{"name":"University of North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emek","family":"Kose","sequence":"additional","affiliation":[{"name":"Frederick National Laboratory for Cancer Research"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taina","family":"Immonen","sequence":"additional","affiliation":[{"name":"Frederick National Laboratory for Cancer Research"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Lifson","sequence":"additional","affiliation":[{"name":"SAIC Frederick, Inc., NCI Frederick"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Laird","sequence":"additional","affiliation":[{"name":"Accelevir Diagnostics, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2381-1151","authenticated-orcid":false,"given":"Brandon","family":"Keele","sequence":"additional","affiliation":[{"name":"Frederick National Laboratory for Cancer Research"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4470-1231","authenticated-orcid":false,"given":"R. Brad","family":"Jones","sequence":"additional","affiliation":[{"name":"Weill Cornell Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Silvestri","sequence":"additional","affiliation":[{"name":"Emory University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0411-7295","authenticated-orcid":false,"given":"Deanna","family":"Kulpa","sequence":"additional","affiliation":[{"name":"Emory University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-7060088\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-7060088\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T07:11:51Z","timestamp":1788505911000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-7060088\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,14]]},"references-count":0,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-7060088\/v1","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1038\/s41564-026-02464-7","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2025,7,14]]},"subtype":"preprint"}}